NCT06689358

Thoracic Paravertebral Block for Postoperative Pain Management After VATS

Thoracic Paravertebral Block for Postoperative Pain Management in PACU After VATS Surgeries: A Randomized Controlled Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 81 (actual)
• Sponsor: King Hussein Cancer Center · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

This randomized controlled trial evaluated the efficacy of a thoracic paravertebral block (TPVB) in reducing opioid requirements and pain intensity in the PACU after video-assisted thoracoscopic surgery (VATS).

Detailed description

This randomized controlled trial evaluated the efficacy of a thoracic paravertebral block (TPVB) in reducing opioid requirements and pain intensity in the PACU after video-assisted thoracoscopic surgery (VATS). Adult patients scheduled for elective VATS who meet the eligibility criteria will be randomized to either Arm: Arm 1: General anesthesia with TPVB; Arm 2: General anesthesia alone (control group). Primary Outcome: to assess Opioid requirement in the PACU

Conditions

• Pain, Postoperative

Interventions

Type	Name	Description
DRUG	0.4 ml/kg of 0.5% bupivacaine	0.4 ml/kg of 0.5% bupivacaine injected into the thoracic paravertebral space

Timeline

• Start date: 2022-11-01
• Primary completion: 2024-08-01
• Completion: 2024-08-01
• First posted: 2024-11-14
• Last updated: 2024-11-14

Locations

1 site across 1 country: Jordan